ERBB2 and breast cancer: More extended analysis of gene expression overlays with protein-protein interaction, transcriptional-regulatory and signaling networks identified distinct driver-networks for each of the three common clinical breast cancer subtypes, that is, oestrogen receptor positive, human epidermal growth factor receptor 2 positive and triple receptor-negative breast cancers [219].